Companies: 10,795·Total market cap: $144.5T
Organogenesis Holdings Inc.

Organogenesis Holdings Inc.

ORGONASDAQHealthcare● Active
$2.38
$-0.04(-1.65%)
Market Cap$306245424
P/E Ratio—
52W High$7.077
52W Low$2.04
SEC Filings

Organogenesis Holdings Inc. (ORGO) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001661181 · ORGO · NASDAQ · as of Jun 9, 2026

Filing snapshot

666
Total Filings
10-Q
Latest Form
2026-05-07
Most Recent
2017
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001661181 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-26
Fiscal Year End
Feb 26, 2026
Accession No.
0001193125-26-076730
Primary Document
orgo-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001661181 · Accession 0001193125-26-076730

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-07
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-07Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
10-QQuarterly Report
10-Q
2026-05-07
View
8-KCurrent Report
8-K
2026-05-07
View
ARSARS
ARS
2026-04-30
View
DEF 14AProxy Statement
DEF 14A
2026-04-30
View
3Initial Statement of Beneficial Ownership
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
2026-02-27
View
10-KAnnual Report
10-K
2026-02-26
View
8-KCurrent Report
8-K
2026-02-26
View
8-KCurrent Report
8-K
2026-02-23
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-12
View
8-KCurrent Report
8-K
2025-12-29
View
10-QQuarterly Report
10-Q
2025-11-06
View
8-KCurrent Report
8-K
2025-11-06
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2025-11-03
View
8-KCurrent Report
8-K
2025-09-25
View
Showing 1–15 of 378 filingsForm 4 / 144 hidden· 666 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001661181  |  Exchange: NASDAQ · Healthcare

Organogenesis Holdings Inc. (NASDAQ: ORGO) has submitted 666 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2017. As a Healthcare sector company with CIK 0001661181, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Organogenesis Holdings Inc.'s most comprehensive regulatory disclosure. The most recent Organogenesis Holdings Inc. 10-K was filed on 2026-02-26 for fiscal year ending 2026. Historical ORGO 10-K annual reports are available from 2015 through 2026.

Investors researching Organogenesis Holdings Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
ESPR SEC Filings →ANGO SEC Filings →EOLS SEC Filings →VREX SEC Filings →EBS SEC Filings →MNPR SEC Filings →SNDL SEC Filings →SIGA SEC Filings →
→ ORGO Financials→ ORGO Earnings→ ORGO Insider Trades

Frequently Asked Questions

ORGO SEC Filings · 8 questions

Organogenesis Holdings Inc. (ORGO) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 666 filings and access original documents at no cost. Organogenesis Holdings Inc.'s CIK is 0001661181.

ORGO SEC filingsOrganogenesis Holdings Inc. SEC documentsfind ORGO 10-K